Evigrade
Critical

Itraconazole × Ticagrelor

Antifungal, triazole×Reversible P2Y12 receptor inhibitor

Mechanism

Strong CYP3A4 inhibitor – ticagrelor rises 5-7 fold. FDA Section 4.3.

Symptoms

Bleeding.

Management

Combination contraindicated.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions